MOTHER3SENSE Study
MOTHER3SENSE
Effects of Maternal Voice, Touch, and Scent on Pain and Stress in Newborns: A Comparison of Three Sensory Interventions
2 other identifiers
interventional
120
1 country
1
Brief Summary
This randomized controlled trial aims to compare the effects of maternal voice, touch, and scent on pain and stress levels in newborns during a routine heel lance procedure. Newborns will be randomly assigned to one of three intervention groups or a control group. Pain and stress responses will be assessed using validated neonatal pain and physiological measures. The findings of this study may help identify effective, low-cost, and non-pharmacological interventions that can be used to reduce pain and stress in newborns during routine clinical procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
June 16, 2026
June 1, 2026
2 months
June 11, 2026
June 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neonatal Infant Pain Scale
The Neonatal Infant Pain Scale (NIPS), originally developed by Lawrence et al. (1993), was adapted into Turkish by Akdovan (Akdovan \& Yıldırım, 1999). NIPS is used to assess procedure-related pain in newborn infants. The scale evaluates five behavioral indicators-facial expression, crying, arm movements, leg movements, and state of arousal-as well as one physiological parameter, breathing pattern. Pain is assessed based on the evaluation of these behavioral and physiological responses.
Before the procedure, during the procedure, and immediately after the procedure
Secondary Outcomes (1)
Newborn stress scale
Before the procedure, during the procedure, and immediately after the procedure
Other Outcomes (2)
Newborn and Maternal Characteristics Form
At baseline
Neonatal Physiological Parameters Monitoring Form
Before the procedure, during the procedure, and immediately after the procedure
Study Arms (4)
Maternal Voice
EXPERIMENTALThe recorded maternal voice will be presented to the newborn before, during, and after the procedure.
Maternal Touch
EXPERIMENTALThe mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.
Maternal Scent
EXPERIMENTALThe newborn will be exposed to maternal breast milk scent during the procedure.
Control
NO INTERVENTIONRoutine heel lance procedures will be performed, and no sensory intervention will be provided.
Interventions
The recorded maternal voice will be presented to the newborn before, during, and after the procedure.
The mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.
The newborn will be exposed to maternal breast milk scent during the procedure.
Eligibility Criteria
You may qualify if:
- Term newborns born between 37 and 42 weeks of gestation
- Newborns without respiratory, cardiac, metabolic, neurological, or infectious diseases
- Newborns not requiring oxygen therapy, phototherapy, or intravenous treatment
- Newborns scheduled to undergo a routine heel lance procedure (metabolic screening or blood sampling)
- Mothers willing to participate in the study
- Written informed consent provided by the parent or legal guardian
- Normal vital signs before the procedure (heart rate, respiratory rate, and oxygen saturation within normal limits)
You may not qualify if:
- Preterm (\<37 weeks) or post-term (\>42 weeks) newborns
- Presence of congenital anomalies or neurological disorders
- Requirement for oxygen therapy, phototherapy, or intravenous treatment
- Respiratory, cardiac, metabolic, neurological, or infectious disease
- Abnormal vital signs before the procedure
- Parent or legal guardian refusal to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kilis Alaeddin Yavaşça State Hospital
Kilis, 79000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor responsible for evaluating pain and stress outcomes will be blinded to group allocation.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 16, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share